InvestSMART

Alcidion Group Limited (ASX:ALC)

ALERT: Price-sensitive ASX Announcement for ALC
Current share price for ALC : $0.100 0.013 (14.94%)+
Announcement
Release
19 Aug 2026 8:00AM
Price at Release
$0.087
Full Release
download
Summary
Alcidion Group Limited reported a strong financial performance for FY26, with a revenue increase of 27% to $51.6M and a 34% rise in Underlying EBITDA to $6.8M. The company expanded its customer base significantly with the acquisition of Kyra flow products and secured important contracts with organizations such as Leidos and UH Sussex NHS. With a positive cash flow and no debt, Alcidion is positioned for continued growth into FY27, with contracted revenue already 32% higher than the previous year. The company continues to focus on expanding its market presence in Australia and the UK, leveraging strategic acquisitions and its Miya Precision platform.
Key Points
  • FY26 revenue of $51.6M, up 27% on the prior corresponding period.
  • Annual Recurring Revenue (ARR) as of 30 June 2026 was $38.3M, up 34%.
  • FY26 Underlying EBITDA increased by 34% to $6.8M.
  • Alcidion had a positive FY26 operating cash flow of $6.8M.
  • Significant contracts signed with Leidos (Australian Defence Force) and UH Sussex NHS.
  • Acquisition of Kyra flow products expanded Alcidion’s customer base in Australia.
  • Record FY27 contracted revenue of $44.9M, up 32%.
  • Gross profit increased by 15% to $41.5M with a gross margin of 80.3%.
  • Strategic expansion through acquisitions and contract wins.
  • Expected continued growth in FY27 with revenue and Underlying EBITDA to exceed FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.